Norwood wins key patent
11:39, Wednesday, 28 June 2006
Sydney - Wednesday - June 28: (RWE Australian Business News) -
Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that a
key patent in the microneedle portfolio licensed from the Massachusetts
Institute of Technology (“MIT”) has been granted in the USA, with all
key claims granted.
The patent relates to transdermal delivery of drugs using a
microneedle device.
The technology is based typically on a circular device that
inserts 2-4 very small microneedles to a very controlled depth,
typically to a shallow depth in the top layers of the skin.
The device and needles are held in place via vacuum while the
drug is delivered.
Add to My Watchlist
What is My Watchlist?